A Phase I Study of Cantuzumab Mertansine Administered as a Single Intravenous Infusion Once Weekly in Patients with Advanced Solid Tumors
Helft, P. R.Volume:
10
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-04-0088
Date:
July, 2004
File:
PDF, 49 KB
english, 2004